Social Capital Hedosophia III announced that shareholders voted to approve its business combination with Clover Health Investments. Approximately 99.5% of the votes cast at the meeting, representing approximately 65.0% of SCH’s outstanding shares, voted to approve the business combination.
The deal is valued at $728 million.
The merger is expected to close today. Trading is expected to begin Jan. 8 on the Nasdaq under CLOV for Class A common stock and “CLOVW” for warrants. Read more.
